| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 2022-12-07 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 2025-07-31 |
James Henson
COO | Chief Operating Officer | 39 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 2013-12-31 |
| Chairman | 62 | 2015-03-31 | |
| Director/Board Member | 64 | 2017-05-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/3/25 | Buy | Company | 142,586 | 1.2514% | ||
| 1/21/25 | Buy | Company | 2,840,101 | 24.9260% | ||
| 11/28/24 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.29% | - | - | 33.68M | ||
| +1.67% | +1.03% | +47.86% | +157.16% | 1,037B | ||
| +0.90% | +3.28% | +52.67% | +50.90% | 615B | ||
| +1.13% | +0.83% | +34.61% | +79.14% | 448B | ||
| +5.14% | +5.40% | +33.75% | +27.79% | 326B | ||
| +1.85% | +3.57% | +37.09% | +40.59% | 293B | ||
| -0.11% | +0.48% | +18.87% | +17.70% | 264B | ||
| +0.25% | -4.62% | -27.66% | -41.76% | 216B | ||
| +0.37% | -1.22% | +18.71% | +55.92% | 198B | ||
| -0.44% | -4.86% | +14.19% | +66.97% | 162B | ||
| Average | +1.04% | +1.12% | +25.56% | +50.49% | 395.27B | |
| Weighted average by Cap. | +1.36% | +1.47% | +34.97% | +75.40% |
Employees
-
Sector
Pharmaceuticals
















